Dhruva Katrekar

Title: Dhruva Katrekar: Innovator in Gene Therapy

Introduction

Dhruva Katrekar is a prominent inventor based in La Jolla, CA (US). He has made significant contributions to the field of gene therapy, particularly in addressing genetic diseases caused by mutations. With a total of 4 patents to his name, Katrekar is at the forefront of innovative solutions in medical science.

Latest Patents

Katrekar's latest patents focus on RNA targeting of mutations via suppressor tRNAs and deaminases. This groundbreaking approach relates to gene therapy for diseases caused by mutations in the stop codon, utilizing modified tRNA. It is estimated that at least 10-15% of all genetic diseases, including muscular dystrophy, certain cancers, beta thalassemia, Hurler syndrome, and cystic fibrosis, fall into this category. Notably, this method is believed to be safer than CRISPR approaches due to minimal off-target effects and the absence of genome-level changes.

Career Highlights

Katrekar is affiliated with the University of California, where he continues to advance his research and innovations. His work is pivotal in developing safer gene therapy techniques that could revolutionize treatment for various genetic disorders.

Collaborations

Katrekar collaborates with fellow researcher Prashant G Mali, enhancing the scope and impact of their research endeavors.

Conclusion

Dhruva Katrekar's contributions to gene therapy exemplify the potential of innovative approaches in addressing complex genetic diseases. His work not only advances scientific understanding but also holds promise for future medical breakthroughs.